|
NEO | Neogenomics Inc |
|
|
NEO | Neogenomics Inc |
| Services-Testing Laboratories |
| Book value per $ invested | $ 1.46 |
| Leverage | 44.79% |
| Market Cap | $ 1.8B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -77.4m |
| Margin | -11.55% |
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.